Effect of arterial pH alterations on metabolic activity of norepinephrine.
D000136:Acid-Base Equilibrium; D000818:Animals; D001639:Bicarbonates / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D005227:Fatty Acids / Q000097:blood; D005260:Female; D005990:Glycerol / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D006985:Hyperventilation / Q000503:physiopathology; D007773:Lactates / Q000097:blood; D008297:Male; D009638:Norepinephrine / Q000378:metabolism* / Q000494:pharmacology*; D010101:Oxygen Consumption; D014325:Tromethamine / Q000494:pharmacology*
D001639:Bicarbonates; D001786:Blood Glucose; D005227:Fatty Acids; D007773:Lactates; D014325:Tromethamine; D005990:Glycerol; D009638:Norepinephrine